Concepedia

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies

Matthew A. Gubens, Matthew Burns, Susan M. Perkins, Melanie San Pedro-Salcedo, Sandy K. Althouse, Patrick J. Loehrer, Heather A. Wakelee

Lung Cancer · 2015 · 51 citations · 15 references

DOI

Concepts

References

15

Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies

Eric A. Engels, Ruth M. Pfeiffer · International Journal of Cancer · 2003 · 504 citations

, , +17

Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.

Patrick J. Loehrer, KyungMann Kim, Seena C. Aisner et al. · Journal of Clinical Oncology · 1994 · 308 citations

, , +15

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman et al. · The Lancet Oncology · 2015 · 299 citations · Full text

, , +8

Chemotherapy for invasive thymoma. A 13-year experience

A. Fornasiero, Otello Daniele, Cristina Ghiotto et al. · Cancer · 1991 · 252 citations · Full text

, , +12

Octreotide Alone or With Prednisone in Patients With Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II Trial

Patrick J. Loehrer, Wei Wang, David H. Johnson et al. · Journal of Clinical Oncology · 2004 · 205 citations

, , +13